Financials data is unavailable for this security.
View more
Year on year Surmodics Inc 's revenues fell -4.91% from 132.58m to 126.08m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a loss of 1.54m to a larger loss of 11.54m.
Gross margin | 73.81% |
---|---|
Net profit margin | -9.15% |
Operating margin | -4.48% |
Return on assets | -6.34% |
---|---|
Return on equity | -9.67% |
Return on investment | -7.22% |
More ▼
Cash flow in USDView more
In 2024, cash reserves at Surmodics Inc fell by 5.30m. However, the company earned 248.00k from its operations for a Cash Flow Margin of 0.20%. In addition the company used 2.94m on investing activities and also paid 2.95m in financing cash flows.
Cash flow per share | -0.2011 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 8.30 |
---|---|
Tangible book value per share | 3.54 |
More ▼
Balance sheet in USDView more
Current ratio | 3.96 |
---|---|
Quick ratio | 3.22 |
Total debt/total equity | 0.2486 |
---|---|
Total debt/total capital | 0.1991 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -644.97%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | -613.97 |